Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.
about
Dietary interventions for maintaining cognitive function in cognitively healthy people in late lifeDietary interventions for prevention of dementia in people with mild cognitive impairmentDietary interventions for maintaining cognitive function in cognitively healthy people in mid lifeVitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid lifeVitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in late lifeVitamin and mineral supplementation for prevention of dementia or delaying cognitive decline in people with mild cognitive impairmentExercise interventions for preventing dementia or delaying cognitive decline in people with mild cognitive impairmentExercise interventions for maintaining cognitive function in cognitively healthy people in mid lifeExercise interventions for maintaining cognitive function in cognitively healthy people in late lifeComputerised cognition-based interventions for maintaining cognitive function in cognitively healthy people in late lifeComputerised cognition-based interventions for preventing dementia in people with mild cognitive impairmentAssociations of cumulative Pb exposure and longitudinal changes in Mini-Mental Status Exam scores, global cognition and domains of cognition: the VA Normative Aging StudyMismatch negativity latency as a biomarker of amnestic mild cognitive impairment in chinese rural elders.Age-correction of test scores reduces the validity of mild cognitive impairment in predicting progression to dementiaAge- and education-adjusted normative data for the Montreal Cognitive Assessment (MoCA) in older adults age 70-99.Attitudes and preferences towards screening for dementia: a systematic review of the literaturePopulation Difference in the Associations of KLOTH Promoter Methylation with Mild Cognitive Impairment in Xinjiang Uygur and Han Populations.Validation of the Dutch version of the quick mild cognitive impairment screen (Qmci-D).Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans.Investigating virtual reality navigation in amnestic mild cognitive impairment using fMRI.Construction of joint confidence regions for the optimal true class fractions of Receiver Operating Characteristic (ROC) surfaces and manifolds.Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment.Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment.Predictors of Medication Adherence in the Elderly: The Role of Mental Health.Neuroprotective Effects of Electroacupuncture on an Animal Model of Bilateral Common Carotid Artery Occlusion.Interview with Dr Carol Brayne, 5 April 2013.Searching for evidence or approval? A commentary on database search in systematic reviews and alternative information retrieval methodologies.Alterations in working memory networks in amnestic mild cognitive impairment.
P2860
Q24186820-C73827F3-A5E1-4F6A-9F78-2A6D9B74529FQ24186832-38015F6E-6567-47A7-AB20-3D25F17E50AAQ24186838-CD9F3E2C-071F-45FB-AB17-21E03B4FE3E6Q24186855-469A0C57-F162-4496-8A80-EA846B4E2F1CQ24186867-1FFAA6ED-67B4-4044-92E6-C1AD3C4B2D29Q24186872-F59787FE-598B-4D9A-A48E-3961CD436F2DQ24188208-39BD2DEE-EB03-43B1-AE0F-6B63B5068968Q24188214-8DE273A3-5896-4050-84E9-DAB3549F4176Q24188220-2FB57EAD-B254-461C-8A31-C55AA2A8EC87Q26471276-93EA5428-9B0B-4F76-9D04-B591091E998EQ26471295-433BC56B-123E-41E3-9DFD-EE3403DDE31CQ29960467-0DF706BE-1083-4A3F-96AD-7EE131B2A3FFQ30415954-5A52CFE1-71E2-4FB5-B455-E33F9BA1D73CQ34110493-E9C3AE03-51DD-4AA3-A9EA-1485D522D7B2Q35622399-07A38C85-70D4-4856-80C9-35047F7C7CBFQ35664387-4B9D7594-ABD4-43F0-8B66-8D68BB5C1A36Q35703387-15BE5236-CE70-4810-BE0D-F5718A23BF61Q35797650-1DF130C9-6E76-4999-B7C3-06D998220C58Q38808542-DC4D6FF2-1BD1-4BFA-9B97-29BBF4649A03Q40506191-7F69329A-3B8C-40F1-8B0D-1766FD9DCFFDQ40668696-AE6DCA17-62B4-4317-ACD4-D5F1580FEC3AQ41015842-FE323ACA-B1D6-4722-AF00-79E0708DFB51Q44368460-FC33BD4D-8488-43CE-96F9-81C346462380Q46945027-0F026590-8DAF-43D4-9BC4-1050909B2A75Q47573462-6EA221B6-09E7-4A28-A0D6-90FCB4D26108Q47613347-C5636581-25C7-43A8-AFB9-4635CA1841CCQ48056418-A55A8D84-88A9-4319-8648-1A3E2BD24712Q48359575-A2331FF5-D719-4845-B2FB-04AC6B3BEFC7Q50680158-128BE05C-C0B7-4E98-88F0-4259D7ED2AAD
P2860
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.
@ast
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.
@en
type
label
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.
@ast
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.
@en
prefLabel
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.
@ast
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.
@en
P2860
P50
P1433
P1476
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.
@en
P2093
Blossom Christa Maree Stephan
Thais Minett
P2860
P356
10.1136/BMJOPEN-2012-001909
P577
2013-02-04T00:00:00Z